Advertising
Showing 1 to 15 of 27 entries
SELL
Great story. World's largest platform for online healthcare. Price target of $161. Down 50% from all-time highs, puzzling. Intellectual property is very solid, so he's not sure if it's mismanaged. It all comes down to execution. He had a stop on it, and got out of the way. Investors should do the same.
Healthcare

Unlock the Weekly Buzzing Stocks

Become a member Or, Sign In
TOP PICK
The valuation had been stretched and it has seen some volatility. There has been some consolidation. The future continues to make sense for companies like this. A disruptor with long-term growth potential. Social media mentions are up 73% over the last 24 hours.
Healthcare
WAIT
Big runup last year during Covid. Valuation got stretched. Volatile. Theme of the business makes some sense. Suffering from lots of action in the options market. Stay away for now until the volatility dies down.
Healthcare
HOLD
Rough ride. Acquisitions, growing pains, disappointing results. Future of these names continues to make sense. Be patient. Chart looks as though it's basing. Higher growth name, so hurt by threat of rising rates. A disruptor, long-term growth, we'll see ups and downs. Put your stop losses in place.
Healthcare
WATCH
It is a leader in US healthcare. He looked at them. They did a big merger and the stocks have pulled back. He had difficulty with it. They are still losing money. Watch it until it becomes more mature.
Healthcare
WATCH
Great run at start of pandemic. Difficulty is newer contracts are with health insurers, so margins are lower. Not as sticky a service as you might think. You can join, and then unjoin. Hasn't held up. Stock's a bit broken. Need to see price pattern improve and subscriber base more stable.
Healthcare
PAST TOP PICK
(A Top Pick Aug 26/20, Down 30%) Typical stay-at-home name. Growing pains. Last quarter had a wider loss than expected. Still sees 25% revenue growth per year. User base and revenue continue to grow. Valuation is a bit expensive. He's being patient, it's the way of the future.
Healthcare
HOLD
Price target is $166.85. Platform to get healthcare from a variety of professionals. Has grown revenue significantly, leader in the category of med-tech. Volatile. Yet to be profitable. A number of acquisitions. Still likes it.
Healthcare
DON'T BUY
The space is too crowded, too many companies with not enough demand.
Healthcare
BUY on WEAKNESS
It's considered a stay-at-home pandemic play, so investors are avoiding it. He thinks TDOCE is better than that with upside. Let others sell it so you can pick it up cheap.
Healthcare

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Dec 01/20, Down 9.6%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with TDOC has triggered our stop at $175. To be disciplined, we recommend covering the balance of the position (along with the previous recommended gain of 27.5%). This creates an overall return on investment of 8.9%.
Healthcare
PARTIAL BUY
It's for real. He likes their game plan and recent acquisition. Problem is, they face more competition. If people think there'll be an economic book, TDC will underperform. Long term, this will be fine, though, because it was a great business model. Teledoc is part of the solution to save Medicare.
Healthcare
BUY

TDOC vs. WLL He likes the industry, especially during Covid. A lot of efficiency gains have been unlocked with telehealth platforms. He prefers TDOC in the US, especially after its recent integration.

Healthcare
BUY
Buy it. This is how people will get healthcare. Hospitals (in the U.S.) are too expensive.
Healthcare

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Dec 01/20, Up 27.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with TDOC has achieved its $247 objective. To be disciplined, we recommend covering 50% of the position. We also recommend trailing up the stop to $175 (previously at $140).
Healthcare
Showing 1 to 15 of 27 entries

Teladoc Inc(TDOC-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 9

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 2

Total Signals / Votes : 13

Stockchase rating for Teladoc Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Teladoc Inc(TDOC-N) Frequently Asked Questions

What is Teladoc Inc stock symbol?

Teladoc Inc is a American stock, trading under the symbol TDOC-N on the New York Stock Exchange (TDOC). It is usually referred to as NYSE:TDOC or TDOC-N

Is Teladoc Inc a buy or a sell?

In the last year, 13 stock analysts published opinions about TDOC-N. 9 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Teladoc Inc.

Is Teladoc Inc a good investment or a top pick?

Teladoc Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Teladoc Inc.

Why is Teladoc Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Teladoc Inc worth watching?

13 stock analysts on Stockchase covered Teladoc Inc In the last year. It is a trending stock that is worth watching.

What is Teladoc Inc stock price?

On 2021-11-26, Teladoc Inc (TDOC-N) stock closed at a price of $109.61.